Brain Sciences


Technology and licensing

We use our proficiency in brain sciences research to fight disease and create new materials and processes. Technology transfer allows us to maximise the commercial potential of our discoveries and transform lives.

UCL spinout tackling eye disease announces £57m launch

Tenpoint Therapeutics, which spun out of UCL in 2021, has announced its launch to address degenerative eye diseases.

Paul Whiting DDI

Accelerating dementia drug discovery

AstronauTx is a biotech company that builds on research from the Alzheimer's Research UK UCL Drug Discovery Institute (DDI). Launched in 2019, it has attracted £7.5 million of investment. 

eye closeup

UCL Brain Sciences spinout is advancing gene therapy treatments

Research originating from the Department of Genetics at the UCL Institute of Ophthalmology hopes to treat devastating eye diseases that cause blindness.